Brief: Virpax Pharmaceuticals Reports 2022 First Quarter Results And Recent Developments
Virpax Pharmaceuticals Inc VRPX.O :
* VIRPAX PHARMACEUTICALS REPORTS 2022 FIRST QUARTER RESULTS
AND
RECENT DEVELOPMENTS
* VIRPAX PHARMACEUTICALS INC - QTRLY NET LOSS PER SHARE
$0.44
Source text for Eikon: ID:nBw9X51nCa
Further company coverage: VRPX.O
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study